These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

412 related items for PubMed ID: 5453852

  • 1. [Treatment of gout with the combination of xanthine oxidase inhibitors and uricosuric agents].
    Delbarre F, Saporta L, de Géry A, Jabre E.
    Rev Rhum Mal Osteoartic; 1970; 37(6):443-50. PubMed ID: 5453852
    [No Abstract] [Full Text] [Related]

  • 2. The treatment of hyperuricemia.
    Lowenthal DT.
    Am Fam Physician; 1976 Jul; 14(1):98-100. PubMed ID: 937167
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in patients with gout.
    Stocker SL, Graham GG, McLachlan AJ, Williams KM, Day RO.
    J Rheumatol; 2011 May; 38(5):904-10. PubMed ID: 21285173
    [Abstract] [Full Text] [Related]

  • 4. Drug treatment of gout.
    Kelley WN, Wyngaarden JB.
    Semin Drug Treat; 1971 Sep; 1(2):119-47. PubMed ID: 4949305
    [No Abstract] [Full Text] [Related]

  • 5. [What is certain in gout therapy?].
    Gottesbüren H, Strohmeyer G.
    Internist (Berl); 1971 Dec; 12(12):518-21. PubMed ID: 4945391
    [No Abstract] [Full Text] [Related]

  • 6. [Drug therapy for idiopathic hyperuricemia--introduction, dose, and side effects].
    Yamanaka H.
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():202-8. PubMed ID: 12629718
    [No Abstract] [Full Text] [Related]

  • 7. [Hyperuricemia and gout--treatment].
    Gröbner W, Walter-Sack I.
    Dtsch Med Wochenschr; 2002 Feb 01; 127(5):210-3. PubMed ID: 11821994
    [No Abstract] [Full Text] [Related]

  • 8. Hyperuricemia and gout: an update.
    Khachadurian AK.
    Am Fam Physician; 1981 Dec 01; 24(6):143-8. PubMed ID: 6895439
    [Abstract] [Full Text] [Related]

  • 9. [Early diagnosis and early treatment of gout].
    Mertz DP.
    Hippokrates; 1968 Jan 15; 39(1):5-12. PubMed ID: 5667616
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of gout.
    Goldfinger SE.
    N Engl J Med; 1971 Dec 02; 285(23):1303-6. PubMed ID: 4941493
    [No Abstract] [Full Text] [Related]

  • 11. Influence of urate-lowering therapies on renal handling of uric acid.
    Ma L, Wei L, Chen H, Zhang Z, Yu Q, Ji Z, Jiang L.
    Clin Rheumatol; 2016 Jan 02; 35(1):133-41. PubMed ID: 25373449
    [Abstract] [Full Text] [Related]

  • 12. A comparative study of the xanthine oxidase inhibitors allopurinol and oxipurinol in man.
    Chalmers RA, Krömer H, Scott JT, Watts RW.
    Clin Sci; 1968 Oct 02; 35(2):353-62. PubMed ID: 5721238
    [No Abstract] [Full Text] [Related]

  • 13. [Uricosuric agent].
    Ohno I.
    Nihon Rinsho; 2008 Apr 02; 66(4):743-7. PubMed ID: 18409525
    [Abstract] [Full Text] [Related]

  • 14. On call. I've had gout for many years. I used to take Zyloprim without any problems, but I just had a severe allergic reaction, so my doctor switched me to Benemid. I'm doing okay, but the drug sometimes upsets my stomach. Do you have any suggestions?
    Simon HB.
    Harv Mens Health Watch; 2010 Jan 02; 14(6):7-8. PubMed ID: 20464796
    [No Abstract] [Full Text] [Related]

  • 15. [Therapy of gout with allopurinol. (Study of 106 cases)].
    Delbarre F, Auscher C, Amor B, de Géry A.
    Sem Hop; 1967 Feb 26; 43(10):634-43. PubMed ID: 4292982
    [No Abstract] [Full Text] [Related]

  • 16. Uricosurics and xanthine oxidase inhibitors: a single-dose assay.
    McMahon FG.
    Curr Ther Res Clin Exp; 1970 Jun 26; 12(6):414-7. PubMed ID: 4987349
    [No Abstract] [Full Text] [Related]

  • 17. The use of the xanthine oxidase inhibitor, allopurinol, in the control of hyperuricaemia, gout and uric acid calculi.
    Emmerson BT.
    Australas Ann Med; 1967 Aug 26; 16(3):205-14. PubMed ID: 6056609
    [No Abstract] [Full Text] [Related]

  • 18. Diagnostic and therapeutic aids in gout and hyperuricemia.
    Bollet AJ.
    Med Times; 1981 Aug 26; 109(8):23-31. PubMed ID: 7278540
    [No Abstract] [Full Text] [Related]

  • 19. [Uricoeliminating or urico-inhibiting agents? Reasons for a choice].
    Cottin S, Prost A.
    Sem Hop; 1972 May 20; 48(24):1739-42. PubMed ID: 4340887
    [No Abstract] [Full Text] [Related]

  • 20. Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis.
    Halpern R, Mody RR, Fuldeore MJ, Patel PA, Mikuls TR.
    Curr Med Res Opin; 2009 Jul 20; 25(7):1711-9. PubMed ID: 19485724
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.